Comparative Genomics of Major Clonal Groups of a Lyme Disease Pathogen
莱姆病病原体主要克隆群的比较基因组学
基本信息
- 批准号:7429047
- 负责人:
- 金额:$ 11.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntigensBacteriaBioinformaticsBlack-legged TickBorreliaBorrelia burgdorferiBorrelia burgdorferi GroupCase StudyCenters for Disease Control and Prevention (U.S.)CharacteristicsChromosome MappingChromosomesCodeCollaborationsCommunitiesComplexDNA SequenceDataDeer TickDepthDevelopmentDiseaseElementsEvolutionFunctional RNAFundingGene Expression RegulationGene FamilyGenesGeneticGenomeGenomicsGoalsHomologous GeneHumanImageryImmunityIndividualInfectionInflammatoryInformaticsIntergenic SequenceInternetInvasiveJointsLeadLipoproteinsLyme DiseaseMapsMolecularMutationNational Institute of Allergy and Infectious DiseaseNatural SelectionsNeuraxisNorth AmericaNucleotidesNumbersOpen Reading FramesOrder SpirochaetalesOutcomePathogenesisPhenotypePhylogenetic AnalysisPhylogenyPlasmidsPopulationPrevalenceQualifyingRangeRateRegulator GenesRelative (related person)ResearchResearch InfrastructureResearch PersonnelRetrievalScoreSequence AlignmentSingle Nucleotide PolymorphismSisterSkinSpecificityStagingSumSurfaceTestingTicksTissuesUnited StatesVariantVector-transmitted infectious diseaseVertebral columnVertebratesVirulenceWidthWorkYangbasecareercollegecomparativedesigngene conservationgenome sequencinggeographic differenceimprovedpathogenpreferencesuccesstherapeutic vaccinetool development
项目摘要
DESCRIPTION (provided by applicant): Lyme disease is the most prevalent and a fast spreading vector-borne infectious disease in the U.S. It is caused by a spirochetal bacterium Borrelia burgdorferi and transmitted by the deer tick Ixodes scapularis. At least 15 genetically distinct clonal groups of the Lyme disease pathogen are circulating in the northeastern U.S., where over 80% of the Lyme disease cases are reported annually. These clonal groups differ in their wildlife prevalence and human pathogenecity. In 2006, a group of six investigators including the PI have initiated a NIH/NIAID-funded 2-year project producing the whole-genome sequences of 17 B. burgdorferi isolates, with the goal of identifying the genetic basis of clone variations in environmental invasiveness and human virulence. Here, the PI proposes a study to complete the goal of the NIAID whole-genome sequencing project by performing the comparative genome analysis of 12 most common clonal groups.
Specific aims are: First, we will identify strain-specific genome changes in a phylogenetic framework. We will identify and align the main chromosomes, orthologous plasmids, and orthologous coding sequences. We will infer a genome-based phylogeny based on chromosomal DNA sequences, so that the strain differences in genome content, genome organization, and DNA sequences can be mapped to different stages during the evolutionary diversification of these clonal groups. Second, we will distinguish more consequential (e.g., adaptive) genomic changes from the lesser (e.g., random) ones by testing for the influence of natural selection. We will identify intergenic sequences important for gene regulation by their sequence conservation, genes critical for B. burgdorferi adaptation (e.g., surface lipoproteins conferring escape from host immunity) by their high non-synonymous nucleotide substitution rates relative to the synonymous rates, genes associated with initial adaptive clonal divergence by comparing the most recently diverged sister clones. Third, we will develop and maintain a website to facilitate the public dissemination of B. burgdorferi comparative genome information, such as genomic changes specific to a high-virulence clonal group. It is unknown why some strains of the Lyme disease bacteria are more pathogenic than others. We will compare the genomes of high- and low-virulence strains to identify the genes contributing to pathogenecity. Virulence-related genome elements are prime targets for designing therapeutics and vaccines.
描述(由申请人提供):莱姆病是美国最流行且传播最快的媒介传播传染病。它由螺旋体细菌伯氏疏螺旋体引起,并由鹿蜱肩胛硬蜱传播。至少 15 个遗传上不同的莱姆病病原体克隆群正在美国东北部流行,每年报告的莱姆病病例中有超过 80% 都在该地区。这些克隆群体在野生动物患病率和人类致病性方面有所不同。 2006 年,包括 PI 在内的六名研究人员发起了一项由 NIH/NIAID 资助的为期 2 年的项目,生产 17 种伯氏疏螺旋体分离株的全基因组序列,目的是确定环境侵袭性中克隆变异的遗传基础和人类毒力。在此,PI 提出一项研究,通过对 12 个最常见的克隆群体进行比较基因组分析来完成 NIAID 全基因组测序项目的目标。
具体目标是:首先,我们将在系统发育框架中识别菌株特异性基因组变化。我们将鉴定并比对主要染色体、直系同源质粒和直系同源编码序列。我们将根据染色体DNA序列推断出基于基因组的系统发育学,以便将基因组内容、基因组组织和DNA序列方面的菌株差异映射到这些克隆群体进化多样化过程中的不同阶段。其次,我们将通过测试自然选择的影响来区分更重要(例如适应性)的基因组变化与较小(例如随机)的基因组变化。我们将通过其序列保守性来鉴定对基因调控重要的基因间序列,通过其相对于同义率的高非同义核苷酸取代率来鉴定对伯氏疏螺旋体适应至关重要的基因(例如,赋予逃避宿主免疫的表面脂蛋白),与通过比较最近分歧的姐妹克隆来确定初始适应性克隆分歧。第三,我们将开发和维护一个网站,以方便公众传播伯氏疏螺旋体比较基因组信息,例如高毒力克隆群特有的基因组变化。目前尚不清楚为什么莱姆病细菌的某些菌株比其他菌株更具致病性。我们将比较高毒力菌株和低毒力菌株的基因组,以确定有助于致病性的基因。毒力相关的基因组元件是设计治疗方法和疫苗的主要目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WEIGANG QIU其他文献
WEIGANG QIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WEIGANG QIU', 18)}}的其他基金
A PET Radiotracer for Diagnostic and Theranostics Imaging in Lyme Disease
用于莱姆病诊断和治疗成像的 PET 放射性示踪剂
- 批准号:
10041529 - 财政年份:2020
- 资助金额:
$ 11.4万 - 项目类别:
Genome Variability and Population Processes of Lyme Disease Pathogens
莱姆病病原体的基因组变异和群体过程
- 批准号:
8810213 - 财政年份:2013
- 资助金额:
$ 11.4万 - 项目类别:
Genome Variability and Population Processes of Lyme Disease Pathogens
莱姆病病原体的基因组变异和种群过程
- 批准号:
8414170 - 财政年份:2013
- 资助金额:
$ 11.4万 - 项目类别:
Genome Variability and Population Processes of Lyme Disease Pathogens
莱姆病病原体的基因组变异和种群过程
- 批准号:
8631038 - 财政年份:2013
- 资助金额:
$ 11.4万 - 项目类别:
Comparative Genomics of Major Clonal Groups of a Lyme Disease Pathogen
莱姆病病原体主要克隆群的比较基因组学
- 批准号:
7901198 - 财政年份:2009
- 资助金额:
$ 11.4万 - 项目类别:
Curricular and Pedagogical Innovations in Quantitative Biology
定量生物学的课程和教学创新
- 批准号:
8104219 - 财政年份:2008
- 资助金额:
$ 11.4万 - 项目类别:
Comparative Genomics of Major Clonal Groups of a Lyme Disease Pathogen
莱姆病病原体主要克隆群的比较基因组学
- 批准号:
7597087 - 财政年份:2008
- 资助金额:
$ 11.4万 - 项目类别:
Curricular and Pedagogical Innovations in Quantitative Biology
定量生物学的课程和教学创新
- 批准号:
7645795 - 财政年份:2008
- 资助金额:
$ 11.4万 - 项目类别:
Comparative Genomics of Major Clonal Groups of a Lyme Disease Pathogen
莱姆病病原体主要克隆群的比较基因组学
- 批准号:
8049058 - 财政年份:2008
- 资助金额:
$ 11.4万 - 项目类别:
Curricular and Pedagogical Innovations in Quantitative Biology
定量生物学的课程和教学创新
- 批准号:
7124126 - 财政年份:2008
- 资助金额:
$ 11.4万 - 项目类别:
相似国自然基金
细菌纳米海绵药物构建含有嵌合抗原受体和sting通路激活的超级巨噬细胞发挥协同抗肿瘤的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤微环境重塑耦合新生抗原递送的细菌基因线路设计与构建
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
细菌外膜囊泡联合递送新生抗原和PD-L1抗体的肿瘤免疫治疗研究
- 批准号:82003259
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
兼具抗原及佐剂性仿生纳米肿瘤疫苗的应用及机制研究
- 批准号:81901683
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于机器学习的细菌保护性抗原自动筛选系统研究
- 批准号:31800770
- 批准年份:2018
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Gut microbiota metabolite sensing licenses IEC to cross talk with T cells to inhibit intestinal inflammation
肠道微生物代谢传感许可 IEC 与 T 细胞交互作用以抑制肠道炎症
- 批准号:
10602998 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
Leveraging early-life microbes to prevent type 1 diabetes
利用生命早期微生物预防 1 型糖尿病
- 批准号:
10659611 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease
定义莱姆病肽聚糖诱导的病理生理学的宿主和病原体决定因素
- 批准号:
10566961 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
Immunological Basis of Autoimmune Addison's Disease in a Novel Canine Model System
新型犬模型系统中自身免疫阿狄森氏病的免疫学基础
- 批准号:
10830527 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别:
A Novel Small Molecule Therapeutic for Acute Graft Versus Host Disease
一种治疗急性移植物抗宿主病的新型小分子疗法
- 批准号:
10759657 - 财政年份:2023
- 资助金额:
$ 11.4万 - 项目类别: